NCT01736540View on ClinicalTrials.gov

An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia
Interventions
DEVICE

MRI scan

MRI was used to measure both liver and cardiac iron loading (R2 by FerriScan and T2\*, respectively).

Trial Locations (13)

2050

Novartis Investigative Site, Camperdown

2065

Novartis Investigative Site, St Leonards

2170

Novartis Investigative Site, Liverpool

2217

Novartis Investigative Site, Kogarah

2500

Novartis Investigative Site, Wollongong

3165

Novartis Investigative Site, East Bentleigh

4101

Novartis Investigative Site, South Brisbane

4102

Novartis Investigative Site, Woolloongabba

5000

Novartis Investigative Site, Adelaide

5042

Novartis Investigative Site, Bedford Park

6000

Novartis Investigative Site, Perth

6009

Novartis Investigative Site, Nedlands

7000

Novartis Investigative Site, Hobart

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY